HIPK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.26469970449261E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.84129999714867E-09 |
Normal-vs-Stage2 |
1.66437999999935E-05 |
Normal-vs-Stage3 |
2.66540000071203E-08 |
Normal-vs-Stage4 |
2.768300E-04 |
Stage1-vs-Stage2 |
8.396200E-01 |
Stage1-vs-Stage3 |
3.202400E-01 |
Stage1-vs-Stage4 |
8.346600E-01 |
Stage2-vs-Stage3 |
3.181000E-01 |
Stage2-vs-Stage4 |
9.667200E-01 |
Stage3-vs-Stage4 |
3.959800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.53430002036714E-09 |
Normal-vs-AfricanAmerican |
7.77430342324692E-11 |
Normal-vs-Asian |
1.437290E-04 |
Caucasian-vs-AfricanAmerican |
4.033000E-01 |
Caucasian-vs-Asian |
5.687400E-01 |
AfricanAmerican-vs-Asian |
5.472600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.56229498624339E-11 |
Normal-vs-Female |
3.417600E-04 |
Male-vs-Female |
9.094300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.24949999999557E-05 |
Normal-vs-Extreme_Weight |
2.1217000045759E-08 |
Normal-vs-Obese |
4.70769999982856E-07 |
Normal-vs-Extreme_Obese |
2.20380000026665E-07 |
Normal_Weight-vs-Extreme_Weight |
5.038400E-01 |
Normal_Weight-vs-Obese |
8.008600E-01 |
Normal_Weight-vs-Extreme_Obese |
1.223790E-01 |
Extreme_Weight-vs-Obese |
2.692400E-01 |
Extreme_Weight-vs-Extreme_Obese |
3.133200E-01 |
Obese-vs-Extreme_Obese |
1.482990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.50689999999632E-05 |
Normal-vs-Age(41-60Yrs) |
3.18799999998731E-06 |
Normal-vs-Age(61-80Yrs) |
8.04389888031665E-12 |
Normal-vs-Age(81-100Yrs) |
1.407330E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.159200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.194200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.203200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.324500E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.581600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.490600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.25900001535229E-09 |
Normal-VS-Type2 PRCC |
3.98840005466639E-09 |
Normal-VS-KIRP CIMP |
6.283800E-02 |
Normal-VS-Unclassified PRCC |
3.81640000000072E-05 |
Type1 PRCC-VS-Type2 PRCC |
3.418000E-01 |
Type1 PRCC-VS-KIRP CIMP |
7.227800E-02 |
Type1 PRCC-VS-Unclassified PRCC |
8.081600E-01 |
Type2 PRCC-VS-KIRP CIMP |
9.116100E-02 |
Type2 PRCC-VS-Unclassified PRCC |
4.252200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.173200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.26940038877888E-10 |
Normal-vs-N1 |
1.68779999998314E-06 |
Normal-vs-N2 |
6.572400E-02 |
N0-vs-N1 |
2.455400E-01 |
N0-vs-N2 |
2.199600E-01 |
N1-vs-N2 |
4.778400E-01 |
|
|